Nykode Therapeutics - Mandatory notification of acquisition of shares by primary insider
Nykode Therapeutics ASA (NYKD) · publisert 2023-10-31 14:30 · vis på NewsWeb
Transaksjoner
| Person | Rolle | Type | Volum | Pris | Dato | ISIN | Handelsplass | Tolket via |
|---|---|---|---|---|---|---|---|---|
| Michael Engsig | – | acquisition | 9 850 | 17,1 NOK | 2023-10-31 | NO0010714785 | XOSL - Oslo Stock Exchange | rules |
Vedlegg
- Attachment 231031.pdf (tekst hentet ut)
Meldingstekst
Oslo, Norway, October 31, 2023 - Primary insider Michael Engsig, Chief Executive Officer of Nykode Therapeutics ASA, has today acquired 9,850 shares in Nykode Therapeutics ASA at a price of NOK 17.10 per share.
Please see further details in the attached document.